Skip to main content
NewslettersWatchlist

Dexcom Inc(DXCM-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low71.75
Day High75.78
Open:72.60
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Motley Fool
1 Stock to Buy Near Its 52-Week Low and Hold for 10 Years
Motley Fool
Why DexCom Stock Flopped on Friday
Barchart
Stocks Settle Mixed as Early Gains Fade on Mixed Corporate News
Barchart
Stocks Rally as Chip Stocks Jump on Western Digital Earnings
Barchart
Stocks Rise on Lower Bond Yields and Positive Earnings Results
Motley Fool
DexCom (DXCM) Q3 2024 Earnings Call Transcript
Motley Fool
Where Will DexCom Be in 5 Years?
Motley Fool
2 Magnificent Stocks to Buy That Are Near 52-Week Lows
Motley Fool
Down More Than 50% From Its High, Is DexCom Stock a Buy?
Motley Fool
2 Beaten-Down Growth Stocks You Might Regret Not Buying
Motley Fool
Is DexCom a Millionaire Maker?
Motley Fool
Down More Than 50%, Is DexCom Stock a Bargain Now?
Motley Fool
2 Magnificent Growth Stocks Down 45% and 32% to Buy Right Now
TheNewswire.com
DXCM DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before October 21, 2024
Motley Fool
DexCom Is Great. Here's Why You Shouldn't Buy It.
Motley Fool
Is DexCom a Millionaire Maker?
Motley Fool
Uh-Oh! Alphabet Is Selling Its Stake in 2 Historically High-Flying Artificial Intelligence (AI) Stocks
Motley Fool
2 Unstoppable Healthcare Stocks to Buy Right Now for Less Than $200
Motley Fool
3 Reasons DexCom Looks Like a No-Brainer Buy Right Now
Motley Fool
Is DexCom a Millionaire-Maker Stock?
Motley Fool
Is It Time to Buy July's Worst-Performing S&P 500 Stocks?
Barchart
S&P Futures Tick Higher Ahead of FOMC Meeting Minutes and U.S. Payrolls Revisions, Target Earnings on Tap

Profile

DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.